ParityBit Technologies is a high-tech company dedicated to providing privacy computing and AI solutions in biomedical and precision medicine fields. The company's big data platform features proprietary privacy computing technology, enabling multiple parties to harmonize, process, explore, and collaborate on cross-domain, multi-modal, and heterogeneous data with full data privacy protection and access control. ParityBit has developed a wide range of AI products powered by cutting-edge deep learning technologies, including cancer genomics analysis, clinical decision support, automated EMR generation, and quality control functionalities. The team consists of seasoned software engineers, machine learning experts, bioinformaticians, and domain experts from various industries. The company, headquartered in the United States, has been instrumental in deploying its products in top-notch hospitals, pharmaceutical companies, biotech, and city data hubs worldwide to support everyday practices for patients, drug discovery, data mining, and R&D. Additionally, ParityBit has hosted large scale clinical and genomic data for organizations globally. As a young and energetic company, ParityBit Technologies holds substantial potential for growth and innovation. For venture capitalists seeking investment opportunities in the healthcare and AI sectors, ParityBit Technologies presents a compelling case with its cutting-edge technology and strong foothold in the industry.
There is no investment information
No recent news or press coverage available for ParityBit Technologies.